COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Pirfenidone Plus M-DDO Gel in Moderate and Severe Acne

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03076320
Recruitment Status : Recruiting
First Posted : March 10, 2017
Last Update Posted : June 7, 2018
Hospital Civil de Guadalajara
Cell Pharma
Information provided by (Responsible Party):
Juan Armendáriz-Borunda, University of Guadalajara

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 31, 2019
Estimated Study Completion Date : March 31, 2019